Covaxin to Be Evaluated as COVID-19 Vaccine Candidate in US, Says Bharat Biotech

"Ocugen, Inc (NASDAQ: OCGN) announced that the US Food and Drug Administration (FDA) has lifted its clinical hold on the Company's Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate, BBV152, known as Covaxin outside the United States. Covaxin to Be Evaluated as COVID-19 Vaccine Candidate in US, Says Bharat Biotech.

Related Keywords

United States ,India ,Hyderabad ,Andhra Pradesh ,Canada ,Bharat , ,Company Investigational New Drug ,Ministry Of Health ,Drug Administration ,Ocugen Inc ,Hyderabad Based Bharat Biotech ,Investigational New Drug ,Bharat Biotech ,More Than ,Family Welfare ,Bbv152 ,Covaxin ,Covaxin Vaccine ,Covid 19 Vaccine ,Us ,Us Food And Drug Administration ,